Lilly signs up to cancer vaccines with CureVac deal
admin 19th October 2017 Uncategorised 0Eli Lilly has signed up CureVac to develop cancer vaccines based on its mRNA technology, in a deal that could potentially be worth more than $2.6 billion to the German biotech.
More: Lilly signs up to cancer vaccines with CureVac deal
Source: News